Clinical Validation Across Key Areas of Use

A placebo-free, 12-week clinical trial assessed the effects of MESOPOROSIL® in 22 women aged 40–66 with visible signs of skin aging and dryness.

Results showed:

• 72.7% of users reported firmer, more hydrated, and more elastic skin by Day 84
• 68.2% noted improved radiance and reduction in fine lines
• Nail strength and hair quality improved over time
• No adverse effects; 100% tolerance, no aftertaste, no gastric distress
• 77.3% were satisfied with results and willing to continue using the product

This study confirms MESOPOROSIL® as an effective, science-backed beauty-from-within ingredientwith excellent tolerability and compliance.
Source: [CosmoDerma 2025, Mohta et al.][30†Publication Cosmoderma]

50 patients with “minor” traumatic vertebral fractures were treated either with:

• Conventional brace therapy alone
• Or brace + MESOPOROSIL® + vitamin D3 + K2 (SilDì® formula)

After 2 months:

• 84.6% of the treated group showed complete bone edema resolution (vs. 15.4% in the control)
• Allowed early removal of spinal orthosis, improving mobility and quality of life
• MRI confirmed superior bone healing
• No side effects reported; safe and well tolerated

These results support MESOPOROSIL®’s key role in accelerating bone regeneration, collagen production, and improving patient recovery.
Source: [PharmaNutrition 2023, Arpino et al.][28†Nutraceutical supplementation]